Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2019

Open Access 01-12-2019 | Methodology

Development and evaluation of decision aids for people considering taking part in a clinical trial: a conceptual framework

Authors: Katie Gillies, Marion K. Campbell

Published in: Trials | Issue 1/2019

Login to get access

Abstract

Ethical requirements of informed consent stipulate that patients approached to participate in a clinical trial be provided with written information that must cover key aspects of the trial. For consent to be deemed “informed”, potential participants should be provided with a range of information about the trials (e.g., the trial aims, the anticipated benefits and potential risks of the trial, and their right to withdraw consent at any time). However, it is well documented that simple provision of this information does not ensure that participants make truly informed decisions. Decision aids, tools that have been shown in a treatment and screening context to support better-quality decisions, are emerging as a possible vehicle to support decision making about trial participation. However, information on how they should best be developed and evaluated in a clinical trial context is lacking. Therefore, this article, drawing on theoretical and empirical insights, outlines a framework for the development and evaluation of decision aids for people considering taking part in a clinical trial.
Literature
1.
2.
3.
4.
Nishimura A, Carey J, Erwin PJ, Tilburt JC, Murad MH, McCormick JB. Improving understanding in the research informed consent process: a systematic review of 54 interventions tested in randomized control trials. BMC Med Ethics. 2013;14:28.CrossRef
5.
Sand K, Kaasa S, Havard Loge J. The Understanding of Informed Consent Information—Definitions and Measurements in Empirical Studies. AJOB Prim Res. 2010;1:2.CrossRef
6.
Flory J, Emanuel E. Interventions to improve research participants’ understanding in informed consent for research: a systematic review. JAMA. 2004;292:1593–601.CrossRef
7.
8.
Stacey D, Légaré F, Lewis K, Barry MJ, Bennett CL, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017;4:CD001431.PubMed
9.
Volk RJ, Llewellyn-Thomas H, Stacey D, Elwyn G. Ten years of the International Patient Decision Aid Standards Collaboration: evolution of the core dimensions for assessing the quality of patient decision aids. BMC Med Inform Decis Mak. 2013;13(Suppl 2):S1.PubMedPubMedCentral
10.
Gillies K, Cotton SC, Brehaut JC, Politi MC, Skea Z. Decision aids for people considering taking part in clinical trials. Cochrane Database Syst Rev. 2015;(11):CD009736.
11.
12.
Fleisher L, Ruggieri DG, Miller SM, Manne S, Albrecht T, Buzaglo J, et al. Application of best practice approaches for designing decision support tools: the preparatory education about clinical trials (PRE-ACT) study. Patient Educ Couns. 2014;96:63–71.CrossRef
13.
Juraskova I, Butow P, Lopez A, Seccombe M, Coates A, Boyle F, et al. Improving informed consent: pilot of a decision aid for women invited to participate in a breast cancer prevention trial (IBIS-II DCIS). Health Expect. 2008;11:252–62.CrossRef
14.
Juraskova I, Butow P, Bonner C, Bell ML, Smith AB, Seccombe M, et al. Improving decision making about clinical trial participation - a randomised controlled trial of a decision aid for women considering participation in the IBIS-II breast cancer prevention trial. Br J Cancer. 2014;111:1–7.CrossRef
15.
Politi MC, Kuzemchak MD, Kaphingst KA, Perkins H, Liu J, Byrne MM. Decision Aids Can Support Cancer Clinical Trials Decisions: Results of a Randomized Trial. Oncologist. 2016;21:1461–70.CrossRef
16.
Sundaresan P, Ager B, Turner S, Costa D, Kneebone A, Pearse M, et al. A randomised controlled trial evaluating the utility of a patient Decision Aid to improve clinical trial (RAVES 08.03) related decision-making. Radiother Oncol. 2017;125:124–9.CrossRef
17.
18.
19.
Coulter A, Dtilwell D, Kryworuchko J, Mullen PD, Ng CJ, van der Weijden T. A systematic development process for patient decision aids. BMC Med Inform Decis Mak. 2013;13(Suppl 2):S2.CrossRef
20.
Elwyn G, O’Connor A, Stacey D, Volk R, Edwards A, Coulter A, et al. International Patient Decision Aids Standards (IPDAS) Collaboration. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006;333:417.CrossRef
21.
Durand MA, Stiel M, Boivin J, Elwyn G. Where is the theory? Evaluating the theoretical frameworks described in decision support technologies. Patient Educ Couns. 2008;71:125–35.CrossRef
22.
23.
McCann S, Campbell MK, Entiwstle VA. Recruitment to clinical trials: a meta-ethnographic synthesis of studies of reasons for participation. J Health Serv Res Policy. 2013;18:233–41.CrossRef
24.
Edwards A, Elwyn G. Shared decision making in health care: achieving evidence based patient choice, 2nd Edition. UK: Oxford University Press; 2009.
25.
Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655.CrossRef
26.
27.
Gillies K, Skea ZC, MacLennan SJ, Ramsay CR, Campbell MK. Determining information for inclusion in a decision-support intervention for clinical trial participation: a modified Delphi approach. Clin Trials. 2013;10:967–76.CrossRef
28.
Gillies K, Huang W, Skea Z, Brehaut J, Cotton S. Patient information leaflets (PILs) for UK randomised controlled trials: a feasibility study exploring whether they contain information to support decision making about trial participation. Trials. 2014;15:62.CrossRef
29.
Hoffman AS, Volk RJ, Saarimaki A, Stirling C, Li LC, Harter M, et al. Delivering patient decision aids on the Internet: definitions, theories, current evidence, and emerging research areas. BMC Med Inform Decis Mak. 2013;13(Suppl 2):S13.CrossRef
30.
Abras C, Maloney-Krichmar D, Preece J. User-centered design In: Bainbridge W, editor. Encyclopedia of human-computer interaction. Thousand Oaks: Sage Publications; 2004. p. 1–14.
31.
Witteman H, Dansokho SC, Colquhoun H, Coutler A, Dugas M, Fagerlin A, et al. User-centered design and the development of patient decision aids: protocol for a systematic review. Syst Rev. 2015;4:11.CrossRef
32.
Adam JA, Khaw FM, Thomson RG, Gregg PJ, Llewellyn-Thomas HA. Patient Decision Aids in Joint Replacement Surgery: A Literature Review and An Opinion Survey of Consultant Orthopaedic Surgeons. Ann R Coll Surg Engl. 2008;90:198–207.CrossRef
33.
Pocock SJ. Clinical trials — a practical approach. Chichester — New York — Brisbane — Toronto — Singapore: Wiley; 1983. p. s265.
34.
Durand MA, Witt J, Joseph-Williams N, Newcombe RG, Politi MC, Sivell S, et al. Minimum standards for the certification of patient decision support interventions: feasibility and application. Patient Educ Couns. 2015;98:462–8.CrossRef
35.
Gillies K, Entwistle V, Treweek SP, Fraser C, Williamson PR, Campbell MK. Evaluation of interventions for informed consent for randomised controlled trials (ELICIT): protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey. Trials. 2015;16:484.CrossRef
36.
Wyatt KD, Branda ME, Anderson RT, Pencille LJ, Montori VM, Hess EP, et al. Peering into the black box: a meta-analysis of how clinicians use decision aids during clinical encounters. Imp Sci. 2014;9:26.CrossRef
37.
Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.CrossRef
38.
Campbell MK, Piaggio G, Elbourne DR, Altman DG, for the CONSORT Group. Consort 2010 statement: extension to cluster randomised trials. BMJ. 2012;345:e5661.CrossRef
39.
Hemming K, Haines TP, Chilton PJ, Girling AJ, Lilford RJ. The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting. BMJ. 2015;350:h391.CrossRef
40.
Hoffmann T, Glasziou P, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687.CrossRef
41.
Madurasinghe VW, Eldridge S, on behalf of the MRC START Group and Forbes G on behalf of the START Expert Consensus Group. Guidelines for reporting embedded recruitment trials. Trials. 2016;17:27.CrossRef
42.
Joseph-Williams N, Lloyd A, Edwards A, Stobbart L, Tomson D, Macphail S, et al. Implementing shared decision making in the NHS: lessons from the MAGIC programme. BMJ. 2017;357:j1744.CrossRef
Metadata
Title
Development and evaluation of decision aids for people considering taking part in a clinical trial: a conceptual framework
Authors
Katie Gillies
Marion K. Campbell
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Trials / Issue 1/2019
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-019-3489-y

Other articles of this Issue 1/2019

Trials 1/2019 Go to the issue

Methodology

Principles and procedures for data and safety monitoring in pragmatic clinical trials

Study protocol

Study of Peri-Articular Anaesthetic for Replacement of the Knee (SPAARK): study protocol for a patient-blinded, randomised controlled superiority trial of liposomal bupivacaine

Study protocol

Enhancing & Mobilizing the POtential for Wellness & Emotional Resilience (EMPOWER) among Surrogate Decision-Makers of ICU Patients: study protocol for a randomized controlled trial

Study protocol

Contributions of vitamin D in the management of depressive symptoms and cardiovascular risk factors: study protocol for a randomized, double-blind, placebo-controlled clinical trial

Study protocol

A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol for the CLEAR clinical trial

Research

Ambassadors of hope, research pioneers and agents of change—individuals’ expectations and experiences of taking part in a randomised trial of an innovative health technology: longitudinal qualitative study